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Opiate receptor-mediated inhibition of adenylate cyclase activity was elicited in membranes ofC6BUI glio- 
ma cells and $49 cyc- lymphoma cells after fusion with opiate receptor-containing membranes derived from 
NG108-15 neuroblastoma x glioma hybrid cells. The fusion was induced by polyethylene glycol using pro- 
cedures developed by Orly and Schramm [(1976) Proc. Natl. Acad. Sci. USA 73, 4410-4414]. Prior to fusion, 
the adenylate cyclase activity of the donor, NGI08-15 cell membrane, was inactivated by N-ethylmaleimide 
treatment. Prostaglandin E I receptors and the stimulatory GTP-binding protein Ns were transferred tothe 
recipient cells along with opiate receptors. Thus, inhibitory receptors can be tranferred to foreign adenylate 
cyclase systems just as stimulatory receptors had earlier been found to do. Furthermore, opiate receptors 
have been shown to function in non-neuronal cells. 
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1. INTRODUCTION 
The adenylate cyclase system is composed, 
minimally, of a catalytic unit, GTP-binding 
transducing proteins (the N or G proteins) and 
receptors [2]. Membrane fusion has been a useful 
tool for the analysis of ~'-adrenergic and glucagon 
receptor-coupled a enylate cyclase [1,3-5]. It has 
also been shown that purified fl-adrenergic recep- 
tor incorporated into liposomes can be coupled to 
adenylate cyclase by fusion with Xenopus 
erythrocytes [6]. These fusion experiments were 
designed to test the ability of such purified recep- 
tors to activate fully the adenylate cyclase system. 
Here, we describe the generation of opiate inhibi- 
tion of  adenylate cyclase in C6 glioma and $49 cyc- 
cells as a result of fusion with membranes of 
NG108-15 neuroblastoma x glioma hybrid ceils 
(treated so as to inactivate adenylate cyclase). The 
experiments how that opiate receptors can be 
coupled to adenylate cyclase in membranes of 
neuronal and non-neuronal origin. 
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2. MATERIALS AND METHODS 
2.1. Cell culture 
Neuroblastoma × glioma, NG108-15, hybrid 
cells were cultured as in [7] except hat they were 
grown in 850-cm 2 roller bottles. Cell pastes were 
stored at -70°C.  C6 BU1 glioma and $49 lym- 
phoma cyc- cells were grown in Dulbecco's 
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modified Eagle medium supplemented with 10°70 
fetal bovine serum also in 850-cm 2 roller bottles. 
2.2. Preparation of membranes for fusion 
All operations described below were carried out 
at 4°C. NG108-15 cell pastes were thawed and 
homogenized in 0.32 M sucrose, 5 mM MgCI2, 
0.01 M Tris-HC1, pH 7.5. After centrifugation for 
30 min at 40000 rpm in a Beckman 60 Ti fixed- 
angle rotor, the crude membranes were resuspend- 
ed in 10 mM Mops, 1 mM mercaptoethanol (pH 
7.4) at a final concentration f 0.5 mg/ml protein. 
Resuspended membranes were incubated for 
25 min with 5 mM NEM in the presence of 
100 mM NaC1 (final concentration). Then 
1.66 vols of 10 mM Mops, 5 mM mercaptoethanol 
(pH 7.4) were added to inactivate the NEM. When 
the binding sites were to be protected with opiates, 
membranes were incubated for 15 min before 
treatment with NEM. The membranes were then 
centrifuged for 30 min at 40000 rpm as before and 
the protein concentration was adjusted to 3 mg/ml 
in 10 mM Mops, 1 mM mercaptoethanol (pH 7.4). 
Liposomes prepared by sonication (using a bath 
sonicator until the suspension became homoge- 
neous) from crude soybean phospholipids (asolec- 
tin) (10 mg/ml) in 10 mM Tris-HCl (pH 7.5), 
1 mM EDTA were added (0.25 mg/ml) and after 
10 min, MgCI2 was added to 10 mM for a further 
15 min incubation. Membranes were diluted with 
10 mM Tris-HCl (pH 7.5) to 1.5 mg/ml and 
divided into aliquots which were placed in small 
polycarbonate tubes in multiples of 1.5 ml. After 
centrifugation at 15000 rpm for 30 min in a 
Beckman 50 Ti fixed-angle rotor, the supernatant 
was removed and pellets were stored at -70°C 
until use. 
2.3. Fusion procedure 
Freshly harvested $49 cyc- or C6 BU1 cells were 
suspended in 5 mM KCI, 135 mM NaCI, 0.8 mM 
MgCI2, 20 mM Tris-HCl (pH 7.4) (solution A) to 
2 x 10 7 cells/ml. 1 ml cells was added to each tube 
of NEM-treated membranes. Cells were centri- 
fuged on top of the pellet at 5000 rpm for 5 min. 
The supernatant was removed, the walls of the 
tubes were dried with absorbent paper and the 
pellets were gently mixed with a glass rod. The 
tubes were transferred to a 37°C bath and 500/zl 
PEG (at 37°C) were added (4.24 g PEG + 5.76 ml 
solution A + 20/zl of 1 N NaOH) and the tubes 
were vortex-mixed for 2 s. 100 s later, 1 ml solu- 
tion A supplemented with 2 mM ATP and 0.1 mM 
EDTA was added followed by a second vortex- 
mixing. Exactly 2 min later a further 9 ml sup- 
plemented solution A was added. After mixing by 
inversion of the parafilm-covered tubes, cen- 
trifugation was carried out at 10000 rpm for 
10 min in a Beckman 50 Ti rotor at 4°C. To the 
pellet was added 3 ml hypotonic medium (5 mM 
MgCI2, 0.1 mM EGTA, 1 mM mercaptoethanol, 
10 mM Tris-HC1, pH 7.5) and the resulting 
suspension was centrifuged at 20000 rpm for 
10 min in a Beckman 50 Ti rotor. The pellets were 
resuspended in 1 ml hypotonic medium. Adenylate 
cyclase assays were performed by the method of 
Salomon et al. [8] as modified by Sharma et al. [9]. 
Assay mixtures (final volume 100/A) contained 
0.2 mM [~r-32p]ATP (2/zCi), 45 mM Tris-HCl (pH 
7.4), 5 mM MgCI2, 10 mM creatine phosphate, 
10 U creatine phosphokinase, 1 mM I [3H]cAMP 
(20000cpm), 50mM NaCI and 10/zM GTP. 
GTPase assays were performed as in [10] except 
that the total membrane preparation was used and 
opiate binding performed as described [11]. 
2.4. Reagents 
[G-3H]cAMP (22.1 Ci/mmol), [3H]DALAMID 
(43.6 Ci/mmol), [7-32p]GTP (tetraethylam- 
monium salt) (10-50 Ci/mmol) and [3H]etorphine 
were purchased from New England Nuclear. 
[ot-32p]ATP (6-10Ci/mmol) was from ICN. 
Asolectin was from Associated Concentrates; PEG 
6000, Mops, NEM, EDTA and isoproterenol were 
from Sigma; other chemicals were of the highest 
grade commercially available. 
3. RESULTS 
3.1. Preparation of NEM membranes 
The general procedure used, as in the work of 
Schramm and co-workers [1,3,4], was to inactivate 
the adenylate cyclase of donor NG108-15 mem- 
branes without markedly affecting receptor- 
binding characteristics. As shown in fig. 1, NEM 
treatment of NG108-15 membranes almost com- 
pletely abolishes adenylate cyclase activity and, 
under the conditions used, has little effect on 
opiate binding to receptors. As shown by others 
[12,13], NaCI protects opiate-binding sites from 
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Fig.l. Susceptibility of opiate agonist binding and 
adenylate cyclase activity in NG108-15 membranes to 
5 mM NEM treatment. Experiments were as described in
section 2 except that at each time indicated, the reaction 
was stopped with mercaptoethanol. Opiate binding and 
adenylate cyclase activities were measured after three 
washes with 10 mM Mops, 1 mM mercaptoethanol (pH 
7.4). (H)  Binding data for membranes preincubated 
with 10 -s M naloxone before NEM treatment. 
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Fig.2. Hormone-stimulated a enylate cyclase activity 
after fusion of increasing amounts of NEM-treated 
NGI08-15 membranes with C6BU~ glioma cells (2 x 107 
cells/fusion). Isoproterenol (5 x 10 -5 M) (A, A) and 
PGE~ (10 -5 M) (a ,  B) stimulation of adenylate cyclase 
with (A, B) and without (A, a) 10 -5 M etorphine. Bars 
indicate SE of quadruplicate determinations. Basal 
activity of approx. 100 pmol/min per ml was subtracted. 
One part of NEM-treated NGI08-15 membranes was 
0.5 mg proteins. 
inactivation with NEM and in our experiments was 
found to be necessary to ensure selective impair- 
ment of adenylate cyclase only. Inclusion of opiate 
ligands (either agonists or antagonists) gave only a 
slight further protection of binding sites and was 
not generally deemed necessary in our ex- 
periments. 
3.2. Fusion with C6 glioma cells 
C6 glioma cells have long been known to be com- 
pletely devoid of opiate receptors [7] but do have 
a well-characterized adenylate cyclase which is 
stimulated by ~?-adrenergic receptors [14]. These 
cells are therefore useful recipients for fusion with 
opiate receptor-containing membranes. The results 
of fusion of a constant amount of C6 cells with 
varying amounts of NEM treated NG108-15 mem- 
branes are described by the data of fig.2. C6 cells 
alone, carried through the fusion procedure, have 
adenylate cyclase activity which is stimulated by 
isoproterenol but unaffected by the opiate agonist, 
etorphine. C6 cells are also unaffected by PGE1 
since they do not carry these receptors. When 
fused with NEM-treated NG108-15 membranes, 
however, opiate receptor activity becomes ap- 
parent as a decrease m adenylate cyclase activity. 
Interestingly, there is the simultaneous appearance 
of stimulation of adenylate cyclase by PGE1 as 
well, because the membranes were derived from 
cells containing such receptors. Not shown in the 
figure are data from the control with NEM-treated 
NG108-15 membranes alone. These controls were 
a part of every experiment and always showed 
negligible amounts of adenylate cyclase activity, 
almost indistinguishable from blanks, without 
enzyme. 
That the opiate inhibition of adenylate cyclase, 
after fusion of membranes with C6 cells, is due to 
a receptor-mediated process is demonstrated by its 
reversal by naloxone (fig.3). This figure shows that 
C~ adenylate cyclase is unaffected by either etor- 
phine or naloxone when fused alone. After fusion 
with NEM-treated NGI08-15 membranes both 
basal and isoproterenol-stimulated a enylate 
cyclase are inhibited by etorphine and this inhibi- 
tion is reversed by naloxone. Again, NEM-treated 
NGI08-15 membranes alone and carried through 
the fusion procedure had no measurable adenylate 
cyclase activity. 
Because opiate inhibition of adenylate cyclase is 
correlated with stimulation of an associated 
GTPase activity [10], we measured low-Kin 
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Fig.3. Coupling of 8 opiate receptors to adenylate 
cyclase of C6 BUI glioma cells by fusion with NEM- 
treated NG108-15 cells. (Left) Results of C6 BU1 cells 
fused alone; (right) glioma cells fused with NEM-treated 
NGI08 membranes. (A) Basal activity; (B,C) 
isoproterenol (5× 10 -5 M)-stimulated adenylate cyclase 
activities. Effects of the opiates are shown in the hatched 
columns. 10 -5 M etorphine was added in every case and 
naloxone (5 × 10 -4 M) was also included in columns C. 
Bars at the top of the columns show the SE of 
quadruplicate d terminations. One part of NEM-treated 
NGI08-15 membranes was 0.5 mg total proteins. 
GTPase activity after fusion of NEM-treated 
NG108-15 membranes with C6 cells. In a typical 
experiment (table 1), the low-Km GTPase present 
in C6 cells or NEM-treated NG108-15 membranes 
fused alone is not stimulated by opiates but when 
the cells and membranes are fused together, small 
but reproducible stimulation by DALAMID is 
observed. 
3.3. Fusion with $49 cyc- lymphoma cells 
The cyc- variant of $49 lymphoma cells is defec- 
tive in the guanine nucleotide regulatory protein, 
Ns, which is required for hormone-stimulated 
adenylate activity [15]. It has been shown that this 
missing component is easily reinserted into the cells 
using several methods, including membrane fusion 
[5]. Thus, hormone-stimulated a enylate cyclase 
measured with these cells after fusion with NEM- 
treated NG108-15 membranes is a useful indication 
of successful fusion. An experiment describing the 
results of such a fusion is shown in rigA. This 
figure shows that both basal (GTP-stimulated) and 
Table 1 
Reconstitution of opiate-stimulated GTPase activity by 
fusion of NEM-treated NGI08-15 membranes with C6 
cells 
Fused components pmol Pi/min per ml 
Basal DALAMID 
(10 -5 M) 
C6 alone 7.4 _+ 0.5 6.9 _+ 0.4 
NEM-treated NG108-15 
membranes alone 1.2 +_ 0.2 1 _+ 0.4 
C6 + NEM-treated 
NGI08-15 membranes 11.4 +_ 0.3 13.8 _+ 0.3 
Data are means _+ SE of quadruplicate d terminations. 
The experiment was performed twice 
hormone (PGE0-stimulated adenylate cyclase ac- 
tivity is markedly increased in cyc- membranes 
after fusion with NEM-treated NG108-15 mem- 
branes and that opiate inhibition of this activity is 
observable. Similar data have been obtained with 
isoproterenol stimulated adenylate cyclase (not 
shown). Thus, opiate receptor function has been 
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Fig.4. Fusion of increasing amounts of NEM treated 
NG108 membranes with $49 cyc- cells (3 × l07 
cells/fusion). Basal (o,o) and PGEI (10-5 M (n,  re)- 
stimulated adenylate cyclase activity in the presence 
(o, m) or absence (o, n) of l0 -5 M etorphine. Bars are 
SE of quadruplicate d terminations. 
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transferred to cyc- membranes along with Ns by 
the fusion procedure. 
4. DISCUSSION 
The present results show that opiate receptors 
can be coupled to adenylate cyclase in cell mem- 
branes originally devoid of such receptors using 
the membrane-cell fusion procedures developed by 
Schramm and colleagues. Thus, inhibitory recep- 
tors share with stimulatory receptors the ability to 
migrate between and presumably within mem- 
branes and to interact with adenylate cyclase from 
extraneous sources. One or all of the components 
of the adenylate cyclase inhibitory as well as 
stimulatory complexes must diffuse readily within 
the membrane. 
Successful reconstitution of opiate receptor 
function by membrane-cell fusion is dependent 
upon the membrane and, therefore, receptor con- 
centration. In our hands, approx. 1 pmol receptor 
is required per fusion in order to observe reliably 
coupling to adenylate cyclase. The assays are per- 
formed on aliquots corresponding to 5°70 or less of 
each fusion reaction and the number of receptors 
present/assay is 2-5-times that used normally 
when assaying opiate inhibition of NG108-15 
membranes. Thus, the efficiency of the fusion 
reaction is high. 
Although opiate receptors are naturally 
associated with neuronal tissue we have shown 
here that they can be incorporated into lymphoid 
cells and function in such cells. Thus, the adenylate 
cyclase machinery of diverse cell types contains 
freely exchangeable components, for inhibition as 
well as for stimulation. Interestingly, C6 glioma 
cells, which are richly endowed with Ni (the in- 
hibitory GTP-binding protein) have not yet been 
shown to contain inhibitory receptors. The inser- 
tion of opiate receptors into these cells has thus 
allowed the first demonstration of inhibitory hor- 
mone function in such cells. 
Demonstration of the insertion of opiate recep- 
tors from membranes into recipient cells is a step 
towards the development of a reconstitution assay 
for receptor function. Experiments are in progress 
which are aimed at incorporation of purified 
opiate receptors from solution with membranes in
ways analogous to those already used for ~- 
adrenergic receptors [6]. 
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